BioPoly® Partial Resurfacing Knee Implant IDE
NCT06915363
This study is recruiting at 4 US sites in 3 states, according to its ClinicalTrials.gov record last updated .
Summary
The goal of this randomized controlled clinical trial is to demonstrate the safety and effectiveness of the BioPoly® Partial Resurfacing Knee Implant for the treatment of cartilage defects of the distal femur in adult patients with knee pain and symptoms who are candidates for surgical intervention of the knee compared to outcomes for the control group.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Knee Pain Chronic
- Knee Osteoarthritis
- Cartilage Damage
- Cartilage Defects of the Knee
- Cartilage or Osteochondral Defects in the Knee
- Cartilage Lesion
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Not applicable
- Ages
- 30 to 65 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Sponsor
- BioPoly LLC
- Last updated on ClinicalTrials.gov
- July 8, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Indiana · 2
- Dupont Hospital · Fort Wayne, IN
- OrthoIndy · Indianapolis, IN
Minnesota · 1
- Mayo Clinic · Rochester, MN
Missouri · 1
- Washington University Orthopedics · Chesterfield, MO
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.